Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1101.0000 -5.30 (-0.48%)
NSE Oct 17, 2025 15:31 PM
Volume: 938.1K
 

1101.00
-0.48%
BP Wealth
declined by 1.3% YoY due to flattish growth in the US, negative contribution from ARV (-19% YoY) and API (-15% YoY) business. EBITDA for the quarter stood at Rs 8.4bn (est. Rs 8.6bn) down 5.3% YoY with EBITDA margins at 22.9% vs 23.9% the same period year ago. PAT for the quarter stood at Rs...
Aurobindo Pharma Ltd. is trading below its 100 day SMA of 1107.0
More from Aurobindo Pharma Ltd.
Recommended